✦ LIBER ✦

4236 POSTER Evaluation of the Efficacy of Enteral Nutrition With FortiCare in Patients Operated for Tumours of the Head and Neck

✍ Scribed by Reshetov, L.; Egorov, G.

Book ID: 123448185
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 39 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)71402-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enteral nutrition in patients with tumou

Enteral nutrition in patients with tumours of the head and neck

✍ Navarro Vila, Carlos; de la Mano, Janvier Soler; Garcia Peris, Pilar; Sanz, Juli 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Home-entral nutrition via PEG of patient

Home-entral nutrition via PEG of patients with head and neck tumours during radiotherapy - The Erlangen experience

✍ R. Fietkau; H. Iro; U. Richter; R. Sauer 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 117 KB

1056 poster Investigating the accuracy o

1056 poster Investigating the accuracy of volume localisation in radiotherapy planning for head and neck and brain tumour patients

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 238 KB

APPLICATION OF HUMAN LEUCOCYTE INTERFERO

APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH TUMOURS OF THE HEAD AND NECK

✍ IKI, D 📂 Article 📅 1981 🏛 The Lancet 🌐 English ⚖ 390 KB

Colonic second primary cancers in patien

Colonic second primary cancers in patients with index tumours of the head and neck

✍ Mr G. W. McGarry; K. Mackenzie; I. Finlay 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Efficacy and safety of gadopentetate dim

Efficacy and safety of gadopentetate dimeglumine in the evaluation of patients with a suspected tumor of the extracranial head and neck

✍ Patricia A. Hudgins; Allen D. Elster; Val M. Runge; Franciska K. Kashanian; Haro 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

## Abstract The clinical efficacy and safety of gadopentetate dimeglumine as a paramagnetic contrast agent for magnetic resonance (MR) imaging of the extracranial head and neck was evaluated in a multicenter trial involving 60 patients. Patients with signs and/or symptoms of a tumor in the nasophar